Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Yuxin Zhou

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0003-3219-8392; OpenAlex author ID A5000565572.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 2)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. FV-429 suppresses cancer cell migration and invasion by EMT via the Hippo/YAP1 pathway in pancreatic cancer cells. Last author DOI 10.1097/cad.0000000000001718↗
  2. FV-429 induces apoptosis by regulating nuclear translocation of PKM2 in pancreatic cancer cells. Last author DOI 10.1016/j.heliyon.2024.e29515↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Zhiying Wang · 1 shared paper, 2025
  2. Xifan Jin · 1 shared paper, 2024

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.